Medication ReconciliationNCT07001137
Medication Reconciliation Process in Clinical Practice
An observational study of Medication Reconciliation and Patient Safety, run by Centre Hospitalier de Saint-Denis at 1 site in France.
Trial summary
This study looks at how reviewing and confirming a patient's medications during a hospital stay can help reduce problems after they go home. It focuses on patients aged 75 and older who were admitted to a short-stay geriatric unit. Read more about this study
- Who is it for?
- Ages 75 years and older
- Conditions the study is for
- Medication Reconciliation, Patient Safety, Geriatrics
- How many people
- 386 participants
- Where
- 1 siteFrance
- Study dates
- 15 Oct 2021to 15 Jan 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 75 years and older
- All sexes
- Older adult
Study population: The study population consists of elderly patients aged 75 years and older who were hospitalized in the short-stay geriatric unit of Casanova Hospital between January 1 and August 31, 2019. These patients typically present with multiple chronic conditions and are often prescribed numerous medications (polymedicated), making them particularly vulnerable to medication errors during care transitions. The population is selected from a hospital-based, real-world clinical setting, and reflects a high-risk group for hospital readmission, emergency visits, and medication-related complications.
Who may be able to join
- All patients admitted to the short-stay geriatric unit of Casanova Hospital Between January 1st and August 31st, 2019
Who cannot join
- Patients who were discharged and then readmitted to the short-stay unit after a brief transfer to another unit (e.g., surgery, internal medicine, or intensive care).
Trial locations and contacts
1 site in 1 country.
About this study
This study looks at how reviewing and confirming a patient's medications during a hospital stay can help reduce problems after they go home. It focuses on patients aged 75 and older who were admitted to a short-stay geriatric unit. The researchers compared three groups:
- Patients who did not receive any medication reconciliation (CTM),
- Patients who received CTM only at hospital admission,
- Patients who received CTM at both admission and discharge.
The goal was to see if this process could lower the number of hospital readmissions, emergency room visits, and deaths within six months after discharge. The study is based on real data from a hospital in 2019 and was conducted by pharmacists and doctors working together.
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Patients who did not receive any medication reconciliation (CTM) | Not described | |
| Patients who received CTM only at hospital admission | Not described | |
| Patients who received CTM at both admission and discharge | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of hospital readmissions within six months following discharge from the short-stay geriatric unit
Measured: Six months after discharge from the short-stay geriatric unit
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Jun 2025
- Study start15 Oct 2021
- Primary completion15 Jan 2022
- Study completion15 Jan 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Medication ReconciliationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 386 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier de Saint-Denis
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07001137
- Sponsor's protocol ID
- 0014_CASA
- Status last verified
- May 2025
- First submitted
- 23 May 2025
- Last updated
- 3 Jun 2025
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Jun 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Medication Reconciliation Process in Clinical Practice
- ClinicalTrials.gov ID
- NCT07001137
- Acronym / sponsor ID
- 0014_CASA
- Conditions
- Medication Reconciliation, Patient Safety, Geriatrics, Hospital Readmission, Pharmaceutical Services, Transitions of Care
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 386 participants (actual)
- Lead sponsor
- Centre Hospitalier de Saint-DenisUniversity, hospital or other
- Study start
- 15 Oct 2021 (actual)
- Primary completion
- 15 Jan 2022 (actual)
- Study completion
- 15 Jan 2022 (actual)
- First posted
- 3 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study looks at how reviewing and confirming a patient's medications during a hospital stay can help reduce problems after they go home. It focuses on patients aged 75 and older who were admitted to a short-stay geriatric unit. The researchers compared three groups:
- Patients who did not receive any medication reconciliation (CTM),
- Patients who received CTM only at hospital admission,
- Patients who received CTM at both admission and discharge.
The goal was to see if this process could lower the number of hospital readmissions, emergency room visits, and deaths within six months after discharge. The study is based on real data from a hospital in 2019 and was conducted by pharmacists and doctors working together.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Patients who did not receive any medication reconciliation (CTM) | – | – |
| Patients who received CTM only at hospital admission | – | – |
| Patients who received CTM at both admission and discharge | – | – |
Who may qualify
- Ages
- 75 years and older
- Sex
- All
- Age groups
- Older adult
- Study population
- The study population consists of elderly patients aged 75 years and older who were hospitalized in the short-stay geriatric unit of Casanova Hospital between January 1 and August 31, 2019. These patients typically present with multiple chronic conditions and are often prescribed numerous medications (polymedicated), making them particularly vulnerable to medication errors during care transitions. The population is selected from a hospital-based, real-world clinical setting, and reflects a high-risk group for hospital readmission, emergency visits, and medication-related complications.
Key inclusion criteria (1 listed)
- All patients admitted to the short-stay geriatric unit of Casanova Hospital Between January 1st and August 31st, 2019
Key exclusion criteria (1 listed)
- Patients who were discharged and then readmitted to the short-stay unit after a brief transfer to another unit (e.g., surgery, internal medicine, or intensive care).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Number of hospital readmissions within six months following discharge from the short-stay geriatric unit
Time frame: Six months after discharge from the short-stay geriatric unit
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Jun 2025.
Related trials for Medication Reconciliation
Not yet recruiting
A Study to Investigate Health Related Quality of Life With a Pharmacist Intervention Compared to Treatment as Usual in Participants With Severe Mental Illness and Substance Use Disorder Receiving Treatment From FACT Teams.
Severe Mental Illness, Substance Use Disorder (SUD)
Enrolling by invitation
Improving Medication Therapy Through a Digital Interdisciplinary Medicine Therapy Optimisation Model
Medication-related Problems, Self-reported Medication Adherence
Enrolling by invitation
Telehealth Education Leveraging Electronic Transitions Of Care for COPD Patients
COPD Exacerbation, Care Transitions
Not yet recruiting
Optimization of Medical Time in the Emergency Department: Impact of an AI-Based System on Prescription Entry
Drug-related Iatrogenesis, Emergency Department
Active, not recruiting
Appropriate Medication Use for Individuals With Intellectual Disabilities - A Matter of Life
Disabilities, Intellectual, Disability, Developmental
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Medication Reconciliation and Patient Safety, run by Centre Hospitalier de Saint-Denis at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of hospital readmissions within six months following discharge from the short-stay geriatric unit (time frame: Six months after discharge from the short-stay geriatric unit). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2025.